pharmaphorum

JULY 31, 2024

GSK raises 2024 forecasts on a strong Q2 led by HIV and cancer drugs, but its shares weakened on litigation concerns and weaker vaccine expectations

Vaccines 111

Vaccines 111

Express Pharma

AUGUST 22, 2024

The US Food and Drug Administration approved and granted emergency use authorisation (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by ModernaTX and Pfizer.

Vaccines 105

Vaccines 105

ID Stewardship

MARCH 7, 2025

Although I have practiced in the area of infectious diseases pharmacy for quite a while now, measles has not been of much clinical relevance to me beyond MMR for routine vaccination. Vaccination is the best way to prevent measles This is an obvious one, but necessary to state right out the gate. MMR is given in 2 doses.

Vaccines 119

Vaccines Immunization Immunity Communication 119

STAT

AUGUST 22, 2024

  The Danish biotech company Bavarian Nordic reported stronger-than-expected earnings and announced a 440,000-dose order for its mpox vaccine from an unnamed European country, CNBC tells us. The order was already accounted for in Bavarian Nordic’s previous 2024 guidance for vaccine manufacturing capacity.

Vaccines 266

Vaccines 266

The Pharmacist

OCTOBER 26, 2023

Pharmacy bodies have called for 2024/25 winter vaccination programme planning to include key parties such as community pharmacy ‘at an appropriately early stage’.

Community Pharmacies 119

Community Pharmacies Vaccines 119

The Pharmacist

FEBRUARY 5, 2024

Pharmacies currently providing the Covid-19 vaccine are being asked by NHS England (NHSE) to extend their service provision contracts until 31 August 2024. The extension covers a potential spring booster programme, with the Joint Committee on Vaccination and Immunisation (JCVI) set to publish their guidance soon.

Vaccines 119

Vaccines 119

The Pharmacist

APRIL 15, 2024

The NHS national booking system for spring Covid-19 vaccination bookings via pharmacies in England is now open. They include adults aged 75 or over as of 30 June 2024, residents in care homes for older adults, and individuals who are immunosuppressed. Those eligible to book appointments are able to do so for next week.

Vaccines 111

Vaccines 111

STAT

DECEMBER 18, 2023

Illumina will either sell Grail to another company or list it on capital markets, consistent with an order from the European Commission, and aims to finalize the terms of the deal by the end of the second quarter of 2024. The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history.

Vaccines 258

Vaccines 258

Pharmaceutical Technology

OCTOBER 13, 2023

The Phase IIb SurVaxM vaccine study will enrol 265 patients and has an estimated completion date in Q2 2024.

Vaccines 111

Vaccines 111

European Pharmaceutical Review

JULY 1, 2024

the CHMP gave a positive opinion for the first nasally administered emergency treatment for allergic reactions” A positive opinion was granted to the mResvia (Respiratory Syncytial Virus (RSV) mRNA vaccine). Eurneffy (epinephrine) offers an alternative method to the standard injection method of administration. 1 virus variant.

Generic Medicine 106

Generic Medicine Vaccines Biosimilars 106

Express Pharma

MAY 16, 2024

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on May 10, 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.

Vaccines 98

Vaccines 98

Pharmaceutical Business Review

SEPTEMBER 16, 2024

This vaccine is intended for individuals aged 12 and above and is now stocked at pharmacies including CVS Pharmacy, Walgreens, Rite Aid among others. The vaccine has been granted Emergency Use Authorization by the US Food and Drug Administration on 30 August 2024. Our vaccine targets JN.1, 1.1.” “Our vaccine targets JN.1,

Vaccines 111

Vaccines Independent Pharmacies 111

Pharmaceutical Technology

SEPTEMBER 12, 2023

adapted monovalent Covid-19 vaccine, COMIRNATY 2023-2024 Formulation. The US FDA has approved Pfizer and BioNTech’s sBLA for Omicron XBB.1.5-adapted

Vaccines 111

Vaccines 111

Express Pharma

MAY 6, 2024

The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. According to its statement, PHARMAP 2024 brought together over 330 professionals from across the industry’s value chain.

Packaging 105

Packaging Pharmaceutical Manufacturing Labelling Pharmaceutical Companies 105

European Pharmaceutical Review

OCTOBER 4, 2023

The World Health Organization ( WHO ) has recommended a new vaccine, R21/Matrix-M, to prevent malaria in children. The R21 vaccine is the second malaria vaccine recommended by WHO. This follows the WHO’s recommendation of the RTS,S/AS01 vaccine for the disease in 2021.

Vaccines 111

Vaccines 111

Express Pharma

OCTOBER 16, 2024

Messenger ribonucleic acid (mRNA)-based innovator pharmaceuticals saw a staggering 800 per cent increase in licensing agreement deal values from 2019 to 2024YTD, driven by the remarkable success of mRNA vaccines during the COVID-19 pandemic. billion in July 2024. billion in 2030. Bristol Myers Squibb formed a multi-year, $1.87

Vaccines 104

Vaccines Immunity Immunization Diabetes 104

Digital Pharmacist

AUGUST 21, 2023

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. The most effective preventive measure against the flu is getting an annual flu vaccine. According to the CDC, in the 2023-2024 season, the U.S.

Vaccines 98

Vaccines Communication Immunity Immunization 98

Express Pharma

AUGUST 27, 2024

Indian Immunologicals Limited (IIL) has announced the development of a live-attenuated, needle-free intranasal booster vaccine against SARS-CoV-2. The vaccine was created using codon deoptimization technology in collaboration with Griffith University, Australia. The danger due to COVID-19 is still not over.

Vaccines 104

Vaccines Immunization Immunity Communication 104

Express Pharma

JUNE 6, 2024

Stakeholders are invited to provide feedback on CDSCO draft guidance within 15 days from the notice’s issuance On May 29, 2024 a draft of the revised “Guidance for Industry on Pharmacovigilance Requirements for Human Vaccines” was released for public consultation by Central Drug Standard Control Organisation (CDSCO).

Vaccines 105

Vaccines Documentation 105

Express Pharma

JUNE 26, 2024

The success of the COVID-19 mRNA vaccines highlighted the major advantages of utilising mRNA technology in vaccine development. Consequently, the FDA has awarded a rising number of review designations to mRNA vaccines in recent years. Implementation of these vaccines is estimated to have prevented 14.4

Vaccines 111

Vaccines Immunity Immunization 111

Pharmaceutical Business Review

SEPTEMBER 6, 2024

This recommendation will aid in the potential authorisation of the vaccine for use in individuals aged six months and older to prevent Covid-19 in the upcoming 2024-2025 autumn/winter season. 1 family of Omicron subvariants for the upcoming vaccination campaign. Moderna’s vaccine targeting the JN.1

Vaccines 104

Vaccines 104

Express Pharma

OCTOBER 25, 2023

With influenza season well underway, vaccination campaigns are in full force in the northern hemisphere. This will reshape the global influenza vaccine market for the upcoming seasons, says GlobalData. Kurdach continues, “When the actual composition of vaccines will revert to trivalent formulations remains another question.

Vaccines 98

Vaccines 98

STAT

FEBRUARY 1, 2024

On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. Damian here with the latest twist in biotech’s recovery, a close look at Bluebird Bio, and the uncertain future of a Covid-19 player. Current Street consensus is $63.5

Drug Pricing 319

Drug Pricing Vaccines Communication Drug Development 319

The Pharmacist

JUNE 24, 2024

‘A number’ of community pharmacies will be commissioned by NHS England (NHSE) to provide the respiratory syncytial virus (RSV) vaccine to older adults from this autumn.

Vaccines 91

Vaccines Community Pharmacies 91

The Pharmacist

JUNE 14, 2024

Pharmacies have been advised they should order alternative vaccines from an approved list, after Sanofi has said its recombinant quadrivalent influenza vaccine (QIVr) would not be available for this year’s flu programme.

Vaccines 88

Vaccines 88

European Pharmaceutical Review

JULY 5, 2024

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. EU pharmacovigilance is stronger with the UK, and UK research is stronger with the EU.”

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Vaccines 98

Express Pharma

SEPTEMBER 12, 2024

Indian Immunologicals (IIL), a vaccine manufacturer, has signed a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) to develop India’s first codon de-optimized live attenuated Zika vaccine. According to the Ministry of Health, as of July 22, 2024, there have been 537 registered Zika cases in the country.

Vaccines 105

Vaccines Hospitals 105

European Pharmaceutical Review

DECEMBER 18, 2023

billion ($260 million) to establish a state-of-the-art research and vaccine development initiative in Denmark. Research at the Novo Nordisk Foundation Initiative for Vaccines and Immunity, or NIVI, will focus initially on creating new or improved vaccines for tuberculosis, influenza , and Group A Streptococcus (GAS).

Vaccines 105

Vaccines Immunization Immunity 105

Pharma Times

MARCH 12, 2024

Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England

Vaccines 139

Vaccines 139

World Pharma News

SEPTEMBER 11, 2023

Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. and Pfizer Inc.

Vaccines 103

Vaccines Hospitals 103

STAT

SEPTEMBER 12, 2024

billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate. Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1

Drug Development 329

Drug Development Vaccines 329

Express Pharma

AUGUST 16, 2024

The biopharmaceutical industry remained resilient in the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve. trillion as on 31 March 2024 to $4 trillion as on 30 June 2024, reveals GlobalData. AstraZeneca reported a 15.5

Diabetes 98

Diabetes Immunity Immunization Vaccines 98

Express Pharma

JANUARY 6, 2025

Urte Jakimaviciute, Senior Director of Market Research and Strategic Intelligence in the healthcare division at GlobalData, comments, Advancements in immunotherapy such as checkpoint inhibitors, CAR-T cell therapies, cancer vaccines, etc.,

Vaccines 97

Vaccines 97

Express Pharma

APRIL 4, 2025

A recent study reveals that a single dose of Bavarian Nordics Jynneos vaccine demonstrated 58 per cent overall effectiveness in preventing mpox infection. A clade I outbreak has been ongoing in Central and Eastern Africa since 2024 and has been responsible for over 21,000 infections to date.

Vaccines 52

Vaccines 52

European Pharmaceutical Review

FEBRUARY 26, 2024

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. CHMP meeting highlights: January 2024 The post CHMP meeting highlights: February 2024 appeared first on European Pharmaceutical Review.

Generic Medicine 98

Generic Medicine Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

Digital Pharmacist

SEPTEMBER 20, 2023

The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.

Independent Pharmacies 105

Independent Pharmacies Nursing Homes Immunity Immunization 105

Express Pharma

JULY 15, 2024

We believe that implementing a fresh PLI scheme for vaccines and biopharmaceutical raw materials is vital now to put the focus back on value-added domestic production with India-for-India and India-for-the-world production. This would stimulate new investments in both R&D and production initiatives.

Medical Records 105

Medical Records Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105